Evidence map›Paper›PMID 38243032›Full record

Trial reportClinical oral investigations2024

Clinical performance of a glass-hybrid system in comparison with a resin composite in two-surface class II restorations: a 5-year randomised multi-centre study.

Ivana Miletić, Anja Baraba, Silvana Jukić Krmek, Tamara Perić, Dejan Marković, Matteo Basso, Cigdem Atalayin Ozkaya, Hande Kemaloglu, Lezize Sebnem Turkun

Open access · hybridAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Clinical oral investigations, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Clinical Performance of Bulk-Fill Versus Incremental Composite Placement Approaches in Vital Posterior Teeth: A 24 Months Randomized Controlled Trial.Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.] · 2026
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Materials (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Ivana MiletićDepartment of Endodontics and Restorative Dentistry, School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10 000, Zagreb, Croatia. miletic@sfzg.hr.
Anja BarabaDepartment of Endodontics and Restorative Dentistry, School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10 000, Zagreb, Croatia.
Silvana Jukić KrmekDepartment of Endodontics and Restorative Dentistry, School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10 000, Zagreb, Croatia.
Tamara PerićClinic for Pediatric and Preventive Dentistry, School of Dental Medicine, University of Belgrade, Dr Subotica 11, Belgrade, 11000, Serbia.
Dejan MarkovićClinic for Pediatric and Preventive Dentistry, School of Dental Medicine, University of Belgrade, Dr Subotica 11, Belgrade, 11000, Serbia.
Matteo BassoCenter of Minimally Invasive, Aesthetic and Digital Oral Rehabilitation (CROMED), IRCCS Galeazzi Orthopaedic Institute, University of Milan, Via Riccardo Galeazzi 4, 20161, Milan, Italy.
Cigdem Atalayin OzkayaDepartment of Restorative Dentistry, Ege University School of Dentistry, Erzene Mah. Ankara Cad. No:172/109, 35040, Bornova/Izmir, Turkey.
Hande KemalogluDepartment of Restorative Dentistry, Ege University School of Dentistry, Erzene Mah. Ankara Cad. No:172/109, 35040, Bornova/Izmir, Turkey.
Lezize Sebnem TurkunDepartment of Restorative Dentistry, Ege University School of Dentistry, Erzene Mah. Ankara Cad. No:172/109, 35040, Bornova/Izmir, Turkey.
Ege University · TRUniversity of Zagreb · HRUniversity of Belgrade · RSUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the 5-year clinical performance of a glass hybrid restorative system and a nano-hybrid resin composite in moderate to large two-surface class II cavities. MATERIALS AND

methodsThis study was carried out by dental schools in Zagreb, Croatia; Izmir, Turkey; Belgrade, Serbia; and Milan, Italy. A total of 180 patients requiring two class-II two-surface restorations in the molars of the same jaw were recruited. The teeth were randomly restored with either a nano-hybrid resin composite (Tetric EvoCeram, Ivoclar Vivadent) or a glass-hybrid material (EQUIA Forte, GC). During the 5-year follow-up, two calibrated evaluators at each centre scored the restorations annually using the FDI-2 scoring system. The survival rates were calculated using the Kaplan-Meier method and compared using non-parametric matched pair tests (p < 0.05).

resultsThere were no statistically significant differences between the overall survival and success rates of the two types of restorations (p>0.05). The success rates (FDI-2 scores 1-3) for EQUIA Forte were 81.9% (average annual failure rate: 3.9%) and 90.7% for Tetric EvoCeram (average annual failure rate: 1.9%). The survival rates (FDI-2 scores 1-4) for EQUIA Forte and Tetric EvoCeram were 94.5% and 94.4%, respectively, with an average annual failure rate of 1.1%.

conclusionsIn terms of success and survival rates, both the glass-hybrid restorative system and the nano-hybrid resin composite have been shown to perform satisfactorily. CLINICAL RELEVANCE: The results of this study indicate that EQUIA Forte can be one of the therapeutic options for moderate to large two-surface class II restorations of posterior teeth.

Indexed as

Dental CariesDental Restoration, PermanentComposite ResinsDental MaterialsGlassGlass Ionomer CementsHumansMolarComposite ResinsDental MaterialsGlass Ionomer CementsClinical studyGlass-hybrid systemNano-hybrid resin compositeTwo-surface restoration

Identifiers

PMID38243032
PMCPMC10799110
OpenAlexW4391053155

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.